
Research ArticleNintedanib (BIBF-1120) inhibits hepatocellular carcinoma growth independent of angiokinase activity
Keywords: HCC; hepatocellular carcinoma; Ab; antibody; IP; immunoprecipitation; p-STAT3; phosphorylated STAT3; PTPs; protein tyrosine phosphatases; SH2; Src homology region 2; SHP-1; SH2 domain-containing phosphatase 1; STAT3; signal transducer and activator of tra